These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 19445279

  • 1. [Neutropenia induced by ticlopidine: a delayed onset case].
    Bellarosa I, Nargi L, Scarano V, Terracciano AM, Orlando V.
    Recenti Prog Med; 2009 Jan; 100(1):27-30. PubMed ID: 19445279
    [Abstract] [Full Text] [Related]

  • 2. Granulocyte colony stimulating factor treatment for delayed recovery of ticlopidine-related neutropenia.
    Hung MJ, Wang CH, Cherng WJ.
    Int J Clin Pract; 2002 Jan; 56(1):70-1. PubMed ID: 11831843
    [Abstract] [Full Text] [Related]

  • 3. [Ticlopidine-induced neutropenia].
    Balbir A, Odeh M, Atias D, Oliven A.
    Harefuah; 1996 Jun 16; 130(12):822-4, 879. PubMed ID: 8885506
    [Abstract] [Full Text] [Related]

  • 4. Agranulocytosis associated with ticlopidine: a possible benefit with filgastim.
    Marinella MA.
    Ann Clin Lab Sci; 1997 Jun 16; 27(6):418-21. PubMed ID: 9433539
    [Abstract] [Full Text] [Related]

  • 5. [Severe neutropenia induced by ticlopidine. Presentation of two cases and review of the literature].
    de la Torre Lima FJ, Prada Parda JL, López López R, del Arco Jiménez A.
    An Med Interna; 2002 Jul 16; 19(7):376-7. PubMed ID: 12224149
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Granulomatous hepatitis and ticlopidine].
    Flamenbaum M, Zenut M, Castillo D, Costes-Charlet N, Kemeny JL, Lavarenne J, Cassan P.
    Therapie; 1997 Jul 16; 52(6):610-1. PubMed ID: 9734117
    [No Abstract] [Full Text] [Related]

  • 8. Ticlopidine induced agranulocytosis managed with granulocyte colony stimulating factor.
    Thomson LE, Stewart JT.
    N Z Med J; 1998 Mar 13; 111(1061):81-2. PubMed ID: 9549559
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Possible ticlopidine-induced cholestatic jaundice.
    Wengrower D.
    Am Fam Physician; 2000 Sep 15; 62(6):1258, 1262. PubMed ID: 11011856
    [No Abstract] [Full Text] [Related]

  • 14. [Ticlopidine-induced pancytopenia: therapy of agranulocytosis with granulocyte colony stimulating factor].
    Schneider AW, Fechler L, Gilfrich HJ.
    Med Klin (Munich); 1996 Jun 15; 91(6):417-9. PubMed ID: 8767319
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adverse haematological effects of ticlopidine. Prevention, recognition and management.
    Love BB, Biller J, Gent M.
    Drug Saf; 1998 Aug 15; 19(2):89-98. PubMed ID: 9704247
    [Abstract] [Full Text] [Related]

  • 17. Risk of neutropenia with clopidogrel.
    Dieter RS.
    J Am Coll Cardiol; 2000 Oct 15; 36(4):1436-7. PubMed ID: 11028512
    [No Abstract] [Full Text] [Related]

  • 18. Ticlopidine induced cholestatic jaundice.
    Yim HB, Lieu PK, Choo PW.
    Singapore Med J; 1997 Mar 15; 38(3):132-3. PubMed ID: 9269384
    [Abstract] [Full Text] [Related]

  • 19. Neutropenia with ticlopidine plus aspirin.
    Neumann FJ, Hall D, Schömig A.
    Lancet; 1997 May 24; 349(9064):1552-3. PubMed ID: 9167482
    [No Abstract] [Full Text] [Related]

  • 20. Pseudomonas bacteremia precipitated by ticlopidine-induced neutropenia.
    Geletko SM, Melbourne KM, Mikolich DJ.
    Ann Pharmacother; 1996 Mar 24; 30(3):246-8. PubMed ID: 8833559
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.